PRESS RELEASE published on 04/10/2025 at 07:40, 1 year ago AFYREN strengthens its Executive Committee with appointment of Laurent Pou as Industrial Director AFYREN strengthens its Executive Committee with the appointment of Laurent Pou as Industrial Director, enhancing industrial skills for AFYREN NEOXY's final start-up phase Executive Committee AFYREN Biobased Ingredients Laurent Pou Industrial Director
PRESS RELEASE published on 04/10/2025 at 07:30, 1 year ago R. STAHL posts record sales in 2024 and for 2025 forecasts stable sales together with earnings at prior-year-level R. STAHL reports record sales in 2024 with forecast for stable sales and earnings in 2025. Annual Report 2024 showcases growth and profitability Record Sales Annual Report Earnings R. STAHL 2025 Forecasts
PRESS RELEASE published on 04/10/2025 at 07:30, 1 year ago Strong start into the year: Nordex Group achieves 2.2 GW of order intake in the first quarter 2025 Nordex Group achieves strong start with 2.2 GW of order intake in the first quarter 2025, driven by Türkiye, Germany, and Finland. Q1/2025 order intake grew by 5 percent year on year Order Intake Germany Nordex Group Finland Türkiye
PRESS RELEASE published on 04/10/2025 at 07:30, 1 year ago Inside Information / Other news releases AFYREN appoints Laurent Pou as Industrial Director to support final start-up phase of AFYREN NEOXY biorefinery. Pou's expertise in industrial plant start-ups key for continuous operation & expansion AFYREN Laurent Pou Industrial Director Biorefinery Start-up Phase
PRESS RELEASE published on 04/10/2025 at 07:00, 1 year ago Relief Therapeutics Reports 2024 Financial Results and Provides Corporate Update Relief Therapeutics reports 2024 financial results and provides a corporate update, emphasizing operational achievements, pipeline momentum, and strengthened financial position Biopharmaceutical Corporate Update Relief Therapeutics Rare Diseases 2024 Financial Results
PRESS RELEASE published on 04/10/2025 at 06:58, 1 year ago DocMorris accelerates Rx growth to 52 per cent and secures CHF 200 million capital increase through firm underwriting DocMorris accelerates Rx growth to 52% and secures CHF 200 million capital increase through underwriting. All business areas grow by 13.4% in the first quarter Capital Increase CHF 200 Million DocMorris Underwriting Rx Growth
PRESS RELEASE published on 04/10/2025 at 06:30, 1 year ago Comet delivers expected Q1 performance Comet Holding AG reports 37.5% increase in Q1 net sales compared to last year, fueled by semiconductor industry growth. Incoming orders rise 30.2% Semiconductor Industry Sales Growth Comet Holding AG Q1 Performance Incoming Orders
PRESS RELEASE published on 04/10/2025 at 06:30, 1 year ago Avolta Publishes Invitation to its Annual General Meeting, to be held on May 14, 2025 Avolta AG publishes invitation to its Annual General Meeting scheduled for May 14, 2025 at Messe und Congress Center Basel, Switzerland Annual General Meeting Switzerland Avolta AG Invitation Messe Und Congress Center
PRESS RELEASE published on 04/10/2025 at 06:08, 1 year ago Tocvan Commences Drilling at Gran Pilar Gold - Silver Project Continues Expansion Zone Drilling Along Northern Corridors Tocvan Ventures Corp. restarts RC drilling at Gran Pilar Gold Silver Project in Sonora, Mexico to explore expansion zone with high-grade gold potential Exploration Tocvan Ventures Corp. RC Drilling Gold-silver Project Gran Pilar
PRESS RELEASE published on 04/10/2025 at 04:55, 1 year ago CO2Coin one of the most successful crypto investments of the coming decades. Clima4Future Ltd. launches CO2Coin, a successful sustainable crypto investment with high growth potential. CO2Coin combines financial innovation with real-world impact on climate projects Sustainable Investment Climate Protection Crypto CO2Coin Clima4Future Ltd.
Published on 05/09/2026 at 01:30, 10 hours 40 minutes ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 12 hours 10 minutes ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 20:38, 15 hours 32 minutes ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 16 hours 57 minutes ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 17 hours 7 minutes ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 1 day 16 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:06, 1 day 17 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 18:17, 1 day 17 hours ago DESCRIPTION OF THE LOUIS HACHETTE GROUP SHARE BUYBACK PROGRAM 2026-2027
Published on 05/07/2026 at 17:45, 1 day 18 hours ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
